Home
NewsNewsOverture Life and CEGYR introduced the first Automated Embryology Center of Excellence to standardize IVF lab processes using robotics and data-driven workflows. By reducing manual variability, the model supports high-volume fertility networks, improves reproducibility, eases embryologist workload, and creates a scalable blueprint for consistent outcomes across global clinics and future-ready clinical operations worldwide.
In a bold move that blends cutting-edge tech with clinical grit, Overture Life, a pioneer in robotic reproductive technologies, has teamed up with Argentina’s CEGYR fertility network to launch what they’re calling a new standard for highly automated embryology operations.
The collaboration places robot-assisted lab systems and smart workflow tools at the core of embryology services across CEGYR’s high-volume fertility clinics and egg-bank facilities. The goal: reduce the age-old problem of inconsistent outcomes tied to manual lab techniques, while opening doors to significantly higher throughput and reliability.
Together, the partners are introducing robotic vitrification, an automated freezing process, along with standardized dish preparation and emerging non-invasive embryo assessment technologies. These systems promise predictable lab performance even as IVF demand outpaces the global supply of skilled embryologists.
CEGYR, with decades of reproductive medicine experience and thousands of procedures annually, will serve as the proving ground for this new model. By collecting real-world data under regulated clinical conditions, the centre hopes to show that automation can slash cycle-to-cycle variability, stabilize lab workflows, and free clinical teams to focus on patient care rather than repetitive manual tasks.
Overture Life’s leadership notes that reproducibility should be built into the system itself, not left to the day-to-day skills of individual technicians. CEGYR’s CEO adds that higher volumes don’t have to mean looser standards; smart automation can equip clinics to grow without sacrificing precision.
With global IVF demand climbing steeply, this alliance may become a template for other large fertility networks looking to balance quality with scale through technological innovation.
Abu Dhabi University and FertiClinic Group have joined forces to establish the FertiClinic Reproductive Research Lab, an advanced reproductive research lab in Abu Dhabi housing IVF, andrology, and cryopreservation facilities. The partnership supports UAE national priorities, bridges academic and clinical expertise, and advances fertility innovation across the region.
NHS Kent and Medway has overhauled its fertility funding policy in a move that sees NHS cuts IVF access for thousands of patients. Effective 1 April 2026, the eligible age ceiling drops from 40 to 38, funded cycles fall from two to one, and embryo transfers are capped at two.
ASEAN's First Telemedicine IVF by Inspire IVF introduces a new era of remote fertility care. Combining AI technology with expert consultation, the platform enables global access, real-time monitoring, and personalised treatment planning, positioning Thailand as a leading hub for fertility services and advancing digital transformation in reproductive healthcare.
CSG.BIO has gone ahead with the acquisition of Hanabusa IVF, Asian Egg Bank, thereby making it a world leader in reproductive medicine and cutting-edge clinics with enhanced patient reach and advanced laboratory capabilities.
Wisconsin lawmakers from both parties are proposing bills to reduce IVF treatment costs. Republicans suggest a $5,000 tax credit for expenses, while Democrats want mandatory insurance coverage. With IVF cycles costing $20,000-$30,000 and 170,000 residents facing infertility, both parties seek affordable solutions through different approaches.
The AI-specialized Infertility Center, which is the largest in Asia, is open in Magok, Seoul and has begun its full-scale medical services from November 17 thereby marking the new era when it comes to fertility in the region.
Alife Health secured CE Mark approval for its AI-powered embryo selection tool, Embryo Predict, under EU MDR, expanding its fertility technology presence across Europe.
